BAUSCH HEALTH COS INC (BHC) Stock Fundamental Analysis

NYSE:BHC • CA0717341071

6.13 USD
+0.2 (+3.37%)
At close: Feb 20, 2026
6.1 USD
-0.03 (-0.49%)
After Hours: 2/20/2026, 8:18:41 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Overall BHC gets a fundamental rating of 4 out of 10. We evaluated BHC against 193 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of BHC while its profitability can be described as average. BHC is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • BHC had positive earnings in the past year.
  • BHC had a positive operating cash flow in the past year.
  • BHC had negative earnings in each of the past 5 years.
  • In multiple years BHC reported negative operating cash flow during the last 5 years.
BHC Yearly Net Income VS EBIT VS OCF VS FCFBHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

  • With an excellent Return On Assets value of 1.35%, BHC belongs to the best of the industry, outperforming 80.63% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 7.44%, BHC belongs to the top of the industry, outperforming 85.34% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for BHC is significantly below the industry average of 12.64%.
  • The last Return On Invested Capital (7.44%) for BHC is above the 3 year average (5.98%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.35%
ROE N/A
ROIC 7.44%
ROA(3y)-1.07%
ROA(5y)-1.65%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.98%
ROIC(5y)5.41%
BHC Yearly ROA, ROE, ROICBHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

  • The Profit Margin of BHC (3.61%) is better than 80.63% of its industry peers.
  • BHC's Operating Margin of 20.68% is amongst the best of the industry. BHC outperforms 87.96% of its industry peers.
  • In the last couple of years the Operating Margin of BHC has grown nicely.
  • The Gross Margin of BHC (70.67%) is better than 78.01% of its industry peers.
  • BHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.68%
PM (TTM) 3.61%
GM 70.67%
OM growth 3Y1.02%
OM growth 5Y4.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.24%
GM growth 5Y-0.44%
BHC Yearly Profit, Operating, Gross MarginsBHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BHC is still creating some value.
  • There is no outstanding debt for BHC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BHC Yearly Shares OutstandingBHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
BHC Yearly Total Debt VS Total AssetsBHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

  • BHC has an Altman-Z score of 0.24. This is a bad value and indicates that BHC is not financially healthy and even has some risk of bankruptcy.
  • BHC has a Altman-Z score (0.24) which is in line with its industry peers.
  • The Debt to FCF ratio of BHC is 19.41, which is on the high side as it means it would take BHC, 19.41 years of fcf income to pay off all of its debts.
  • BHC has a Debt to FCF ratio of 19.41. This is in the better half of the industry: BHC outperforms 75.92% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 19.41
Altman-Z 0.24
ROIC/WACC1.09
WACC6.85%
BHC Yearly LT Debt VS Equity VS FCFBHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • BHC has a Current Ratio of 1.30. This is a normal value and indicates that BHC is financially healthy and should not expect problems in meeting its short term obligations.
  • BHC has a worse Current ratio (1.30) than 76.44% of its industry peers.
  • BHC has a Quick Ratio of 1.30. This is a bad value and indicates that BHC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.97, BHC is not doing good in the industry: 78.53% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.97
BHC Yearly Current Assets VS Current LiabilitesBHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • BHC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.53%.
  • The Earnings Per Share has been decreasing by -1.23% on average over the past years.
EPS 1Y (TTM)-0.53%
EPS 3Y6.78%
EPS 5Y-1.23%
EPS Q2Q%-6.09%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.26%

3.2 Future

  • The Earnings Per Share is expected to decrease by -1.92% on average over the next years.
  • Based on estimates for the next years, BHC will show a decrease in Revenue. The Revenue will decrease by -1.38% on average per year.
EPS Next Y14.38%
EPS Next 2Y-2.29%
EPS Next 3Y-7.1%
EPS Next 5Y-1.92%
Revenue Next Year4.23%
Revenue Next 2Y2%
Revenue Next 3Y-2.31%
Revenue Next 5Y-1.38%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
BHC Yearly Revenue VS EstimatesBHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
BHC Yearly EPS VS EstimatesBHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

9

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 1.63, the valuation of BHC can be described as very cheap.
  • Based on the Price/Earnings ratio, BHC is valued cheaply inside the industry as 99.48% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.99. BHC is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 1.43, the valuation of BHC can be described as very cheap.
  • BHC's Price/Forward Earnings ratio is rather cheap when compared to the industry. BHC is cheaper than 98.95% of the companies in the same industry.
  • BHC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 1.63
Fwd PE 1.43
BHC Price Earnings VS Forward Price EarningsBHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BHC is valued cheaper than 94.76% of the companies in the same industry.
  • 99.48% of the companies in the same industry are more expensive than BHC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.1
EV/EBITDA 6.65
BHC Per share dataBHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of BHC may justify a higher PE ratio.
  • BHC's earnings are expected to decrease with -7.10% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y-2.29%
EPS Next 3Y-7.1%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • BHC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BAUSCH HEALTH COS INC

NYSE:BHC (2/20/2026, 8:18:41 PM)

After market: 6.1 -0.03 (-0.49%)

6.13

+0.2 (+3.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-18
Earnings (Next)04-28
Inst Owners45.78%
Inst Owner Change-1.43%
Ins Owners10.79%
Ins Owner Change11.53%
Market Cap2.27B
Revenue(TTM)N/A
Net Income(TTM)362.00M
Analysts48.89
Price Target7.45 (21.53%)
Short Float %1.66%
Short Ratio2.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.24%
Min EPS beat(2)-7.07%
Max EPS beat(2)2.59%
EPS beat(4)1
Avg EPS beat(4)-8.49%
Min EPS beat(4)-25.13%
Max EPS beat(4)2.59%
EPS beat(8)4
Avg EPS beat(8)-3.92%
EPS beat(12)7
Avg EPS beat(12)-2.32%
EPS beat(16)8
Avg EPS beat(16)-5.93%
Revenue beat(2)2
Avg Revenue beat(2)0.5%
Min Revenue beat(2)0.36%
Max Revenue beat(2)0.64%
Revenue beat(4)3
Avg Revenue beat(4)-0.05%
Min Revenue beat(4)-1.57%
Max Revenue beat(4)0.64%
Revenue beat(8)6
Avg Revenue beat(8)0.85%
Revenue beat(12)9
Avg Revenue beat(12)1.1%
Revenue beat(16)9
Avg Revenue beat(16)-0.08%
PT rev (1m)0.7%
PT rev (3m)2.43%
EPS NQ rev (1m)-0.59%
EPS NQ rev (3m)0.79%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)-0.54%
Revenue NQ rev (1m)-0.4%
Revenue NQ rev (3m)-0.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 1.63
Fwd PE 1.43
P/S 0.23
P/FCF 2.1
P/OCF 1.51
P/B N/A
P/tB N/A
EV/EBITDA 6.65
EPS(TTM)3.75
EY61.17%
EPS(NY)4.29
Fwd EY69.97%
FCF(TTM)2.92
FCFY47.68%
OCF(TTM)4.06
OCFY66.25%
SpS27.04
BVpS-1.52
TBVpS-44.98
PEG (NY)0.11
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.35%
ROE N/A
ROCE 9.41%
ROIC 7.44%
ROICexc 7.91%
ROICexgc 35.57%
OM 20.68%
PM (TTM) 3.61%
GM 70.67%
FCFM 10.81%
ROA(3y)-1.07%
ROA(5y)-1.65%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.98%
ROIC(5y)5.41%
ROICexc(3y)6.26%
ROICexc(5y)5.63%
ROICexgc(3y)44%
ROICexgc(5y)37.54%
ROCE(3y)7.57%
ROCE(5y)6.85%
ROICexgc growth 3Y34.27%
ROICexgc growth 5Y-5.74%
ROICexc growth 3Y14.02%
ROICexc growth 5Y12.75%
OM growth 3Y1.02%
OM growth 5Y4.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.24%
GM growth 5Y-0.44%
F-Score7
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 19.41
Debt/EBITDA 6.2
Cap/Depr 34.45%
Cap/Sales 4.21%
Interest Coverage 250
Cash Conversion 45.65%
Profit Quality 299.45%
Current Ratio 1.3
Quick Ratio 0.97
Altman-Z 0.24
F-Score7
WACC6.85%
ROIC/WACC1.09
Cap/Depr(3y)22.53%
Cap/Depr(5y)20.55%
Cap/Sales(3y)3.31%
Cap/Sales(5y)3.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.53%
EPS 3Y6.78%
EPS 5Y-1.23%
EPS Q2Q%-6.09%
EPS Next Y14.38%
EPS Next 2Y-2.29%
EPS Next 3Y-7.1%
EPS Next 5Y-1.92%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.26%
Revenue Next Year4.23%
Revenue Next 2Y2%
Revenue Next 3Y-2.31%
Revenue Next 5Y-1.38%
EBIT growth 1Y18.58%
EBIT growth 3Y5.56%
EBIT growth 5Y6.8%
EBIT Next Year16.54%
EBIT Next 3Y4.34%
EBIT Next 5Y-1.3%
FCF growth 1Y21.39%
FCF growth 3Y3.22%
FCF growth 5Y0.55%
OCF growth 1Y34.83%
OCF growth 3Y3.85%
OCF growth 5Y1.25%

BAUSCH HEALTH COS INC / BHC FAQ

What is the ChartMill fundamental rating of BAUSCH HEALTH COS INC (BHC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BHC.


Can you provide the valuation status for BAUSCH HEALTH COS INC?

ChartMill assigns a valuation rating of 9 / 10 to BAUSCH HEALTH COS INC (BHC). This can be considered as Undervalued.


Can you provide the profitability details for BAUSCH HEALTH COS INC?

BAUSCH HEALTH COS INC (BHC) has a profitability rating of 6 / 10.


Can you provide the financial health for BHC stock?

The financial health rating of BAUSCH HEALTH COS INC (BHC) is 2 / 10.